@FierceBiotech: What's making Big #Pharma pay for mobile tech? Drives to streamline trials ops and, of course, sell more drugs. Story | Follow @FierceBiotech
@JohnCFierce: Scientists strip the brake off of T cells in mouse study, amp up immune response. Article | Follow @JohnCFierce
@RyanMFierce: Educators jumping aboard the Big Data bandwagon with industry clamoring for help #bioinformatics--@Forbes. Article | Follow @RyanMFierce
@MarkHFierce: B.U. has found some genetic triggers behind the onset of menopause. Info could help treat age-related diseases. Release | Follow @MarkHFierce
@FierceMedDev: An interesting read: Med tech consolidation brings a need for focus. Here are 2 ways to get it. Article | Follow @FierceMedDev
> Shares of Alexza Pharmaceuticals ($ALXA) slid 19% this morning after the biotech reported that the FDA had extended its review of the anti-psychotic Adasuve by three months. Report
> Spectrum Pharmaceuticals ($SPPI) reported some positive new data for its lymphoma drug Zevalin. Patients taking a Zevalin combo had a distinctly higher two-year survival rate compared to patients receiving chemo alone. Story
> The preclinical stage biotech Verastem plans to roll out an unusual $45 million IPO this week. In its SEC filings the biotech, which was founded by Christoph Westphal, has noted that the company's financial backers have committed to buying about a third of the offering. Story
> Exelixis ($EXEL) is claiming positive preliminary data from a Phase II study of cabozantinib in hepatocellular carcinoma. Release
Pharma News
@FiercePharma: Patent cliff + R&D disappointments + regulatory issues + economic woes = a tough 2012 for pharma, Fitch says. More | Follow @FiercePharma
> Tysabri label change could add $1B to sales. News
> Gov't probes laundry list of drugmakers. Story
> Roche workers protest contract hiring in Poland. News
> GSK chief wants Olympics lab to outlast games. Article
> Why drugmakers are so enamored of rare-disease meds. Item
Medical Devices News
> Stent advances expected to prop up European market. Story
> Covidien's Almeida to add title of chairman. Piece
> EU breast implant scandal may affect FDA's view on faster device approvals. Article
IT News
> Big Pharma testing waters with mobile tech. More
> Oracle injects genomics capability into analytics platform. News
> Medidata chief calls company 'the cloud' for clinical data. Story
> Consumers to pharma: Let's be Facebook friends (or not). Item
> Oracle, Parexel among leaders in CTMS market poised to hit $1.3B. More
> FDA brings new work flow software into its labs. Article
And Finally... Chinese officials have approved the world's first vaccine for hepatitis E. Story